XNYS
HIMS
Market cap13bUSD
May 20, Last price
61.08USD
1D
-2.02%
1Q
-11.14%
IPO
513.87%
Name
Hims & Hers Health Inc
Chart & Performance
P/E
104.41
P/S
8.91
EPS
0.58
Div Yield, %
—
Shrs. gr., 5y
56.59%
Rev. gr., 5y
78.03%
Revenues
1.48b
+69.33%
Net income
126m
P
CFO
251m
+241.69%
Earnings
Aug 04, 2025
Profile
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | 1,476,514 69.33% | 872,000 65.49% | 526,916 93.81% | ||||
Cost of revenue | 1,228,809 | 781,596 | 518,210 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 247,705 | 90,404 | 8,706 | ||||
NOPBT Margin | 16.78% | 10.37% | 1.65% | ||||
Operating Taxes | (54,327) | 1,975 | (31) | ||||
Tax Rate | 2.18% | ||||||
NOPAT | 302,032 | 88,429 | 8,737 | ||||
Net income | 126,038 -635.28% | (23,546) -64.15% | (65,678) -38.99% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | (83,039) | (1,999) | (1,655) | ||||
BB yield | 1.45% | 0.11% | 0.13% | ||||
| Debt | |||||||
Debt current | 1,889 | 2,562 | 1,658 | ||||
Long-term debt | 20,801 | 18,615 | 8,956 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 22 | 3,010 | |||||
Net debt | (277,561) | (199,804) | (169,867) | ||||
| Cash flow | |||||||
Cash from operating activities | 251,084 | 73,483 | (26,531) | ||||
CAPEX | (41,655) | (17,220) | (7,247) | ||||
Cash from investing activities | (19,048) | (12,106) | 34,699 | ||||
Cash from financing activities | (107,845) | (11,475) | (33,127) | ||||
FCF | 254,799 | 47,634 | 8,912 | ||||
| Balance | |||||||
Cash | 300,251 | 220,981 | 179,625 | ||||
Long term investments | 856 | ||||||
Excess cash | 226,425 | 177,381 | 154,135 | ||||
Stockholders' equity | (242,439) | (368,278) | (344,885) | ||||
Invested Capital | 730,500 | 723,558 | 663,980 | ||||
ROIC | 41.54% | 12.75% | 1.36% | ||||
ROCE | 50.75% | 25.45% | 2.73% | ||||
| EV | |||||||
Common stock shares outstanding | 236,809 | 209,345 | 204,516 | ||||
Price | 24.18 171.69% | 8.90 38.85% | 6.41 -2.14% | ||||
Market cap | 5,726,039 207.33% | 1,863,168 42.12% | 1,310,948 7.15% | ||||
EV | 5,448,478 | 1,663,364 | 1,141,081 | ||||
EBITDA | 264,793 | 99,919 | 16,180 | ||||
EV/EBITDA | 20.58 | 16.65 | 70.52 | ||||
Interest | 2,988 | ||||||
Interest/NOPBT | 34.32% | ||||||